CRISPR Therapeutics AG Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 11/12/2025 | 9.79 M | $634.29 M | -3.89% | 11.24% |
| BLACKROCK, INC. | 11/12/2025 | 7.05 M | $456.92 M | 16.22% | 8.10% |
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2025 | 5.65 M | $366.13 M | 0.99% | 6.49% |
| ORBIS ALLAN GRAY LTD | 11/14/2025 | 4.98 M | $322.89 M | 80.21% | 5.72% |
| STATE STREET CORP | 11/14/2025 | 4.01 M | $259.71 M | 22.52% | 4.60% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 3.28 M | $212.75 M | -10.87% | 3.77% |
| VANGUARD GROUP INC | 11/07/2025 | 2.36 M | $153.25 M | 2.90% | 2.72% |
| UBS GROUP AG | 11/13/2025 | 2.34 M | $151.59 M | -17.74% | 2.69% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 10/27/2025 | 2.16 M | $140.23 M | -10.40% | 2.49% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 11/12/2025 | 2.16 M | $140.18 M | -10.38% | 2.49% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.14 M | $138.79 M | 3.34% | 2.46% |
| SR ONE CAPITAL MANAGEMENT, LP | 11/12/2025 | 2.04 M | $132.13 M | 94.36% | 2.34% |
| FMR LLC | 11/13/2025 | 1.89 M | $122.21 M | -2.25% | 2.17% |
| MORGAN STANLEY | 11/14/2025 | 1.40 M | $90.60 M | 173.35% | 1.61% |
| ECOR1 CAPITAL, LLC | 11/14/2025 | 1.39 M | $90.04 M | 0.00% | 1.60% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.12 M | $72.85 M | -22.39% | 1.29% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2025 | 1.06 M | $68.61 M | -33.33% | 1.22% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 1.04 M | $67.71 M | -32.42% | 1.20% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 985.77 K | $63.89 M | 5.63% | 1.13% |
| LOOMIS SAYLES & CO L P | 11/13/2025 | 909.71 K | $58.96 M | 6.17% | 1.04% |
| CITADEL ADVISORS LLC | 11/14/2025 | 888.00 K | $57.55 M | 202.66% | 1.02% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 877.03 K | $56.83 M | -4.43% | 1.01% |
| CITADEL ADVISORS LLC | 11/14/2025 | 851.00 K | $55.15 M | -12.79% | 0.98% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 814.32 K | $52.78 M | 5.76% | 0.94% |
| NORTHERN TRUST CORP | 11/14/2025 | 779.93 K | $50.55 M | 2.47% | 0.90% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 705.50 K | $45.72 M | 43.42% | 0.81% |
| JPMORGAN CHASE & CO | 11/26/2025 | 593.42 K | $38.46 M | 84.81% | 0.68% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 572.97 K | $37.13 M | -57.39% | 0.66% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 551.00 K | $35.71 M | -31.73% | 0.63% |
| ROYAL BANK OF CANADA | 11/14/2025 | 466.17 K | $30.21 M | 38.27% | 0.54% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 453.60 K | $29.40 M | 94.85% | 0.52% |
| PEAK6 LLC | 11/14/2025 | 371.10 K | $24.05 M | -6.31% | 0.43% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 360.30 K | $23.35 M | 169.69% | 0.41% |
| JANE STREET GROUP, LLC | 11/14/2025 | 358.30 K | $23.22 M | 62.27% | 0.41% |
| BARCLAYS PLC | 11/12/2025 | 349.85 K | $22.67 M | -8.08% | 0.40% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 311.86 K | $20.27 M | 18.99% | 0.36% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 304.61 K | $19.74 M | 0.88% | 0.35% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 303.18 K | $19.65 M | 28.61% | 0.35% |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 11/05/2025 | 283.11 K | $18.35 M | 44.74% | 0.33% |
| CONTRARIUS GROUP HOLDINGS LTD | 11/12/2025 | 270.35 K | $17.52 M | -27.90% | 0.31% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 11/10/2025 | 238.96 K | $15.49 M | -50.73% | 0.27% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 233.54 K | $15.14 M | 5.87% | 0.27% |
| LPL FINANCIAL LLC | 11/12/2025 | 211.06 K | $13.68 M | 8.47% | 0.24% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 192.59 K | $12.29 M | -18.37% | 0.22% |
| BANK OF MONTREAL /CAN/ | 11/13/2025 | 187.22 K | $12.13 M | -62.08% | 0.22% |
| BANK OF MONTREAL /CAN/ | 11/13/2025 | 183.00 K | $11.86 M | 0.00% | 0.21% |
| NUVEEN, LLC | 11/12/2025 | 182.84 K | $11.85 M | -1.09% | 0.21% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 174.62 K | $11.32 M | -23.55% | 0.20% |
| O'NEIL GLOBAL ADVISORS, INC. | 11/10/2025 | 168.72 K | $10.93 M | 100.00% | 0.19% |
| JANE STREET GROUP, LLC | 11/14/2025 | 168.70 K | $10.93 M | -15.44% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CRISPR Therapeutics AG institutional Ownership - FAQ's
During the previous two years, 617 institutional investors and hedge funds held shares of CRISPR Therapeutics AG. The most heavily invested institutionals were:
ARK Investment Management LLC: 9.79 M
BlackRock, Inc.: 7.05 M
Capital International Investors: 5.65 M
Orbis Allan Gray Ltd: 4.98 M
STATE STREET CORP: 4.01 M
T. Rowe Price Investment Management, Inc.: 3.28 M
82.95% of CRISPR Therapeutics AG stock is owned by institutional investors.
Institutional investors have bought a total of 79.56 M shares in the last 24 months. This purchase volume represents approximately $5.39 B in transactions.